Article: Awareness of a mesenteric mass as a common manifestation of ileal neuroendocrine tumor

Omori et al. reported a case of multiple liver metastases originating from synchronous double cancer of "primary mesenteric neuroendocrine tumor" and rectal cancer. However, the "primary mesenteric neuroendocrine tumor" might be a misrecognition of mesenteric metastasis from ileal neuroendocrine tumor. Ileal neuroendocrine tumor is extremely rare in Japan. Herein, we aim to describe the characteristics of ileal neuroendocrine tumor and mesenteric mass as its common manifestation in reference to their reported case.

Citing Articles

Two synchronous primary mesenteric neuroendocrine tumors in a patient: a case report.

Symeonidou E, Fouza A, Gkoutziotis I, Nikolaidou C, Petras P, Mpallas K Front Surg. 2024; 11:1323468.

PMID: 38638140 PMC: 11024421. DOI: 10.3389/fsurg.2024.1323468.

References

1.

Wang S, Parekh J, Zuraek M, Venook A, Bergsland E, Warren R . Identification of unknown primary tumors in patients with neuroendocrine liver metastases. Arch Surg. 2010; 145(3):276-80. DOI: 10.1001/archsurg.2010.10. View

2.

Howe J, Cardona K, Fraker D, Kebebew E, Untch B, Wang Y . The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society. Pancreas. 2017; 46(6):715-731. PMC: 5502737. DOI: 10.1097/MPA.0000000000000846. View

3.

Squires 3rd M, Adsay N, Schuster D, Russell M, Cardona K, Delman K . Octreoscan Versus FDG-PET for Neuroendocrine Tumor Staging: A Biological Approach. Ann Surg Oncol. 2015; 22(7):2295-301. DOI: 10.1245/s10434-015-4471-x. View

4.

Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y . Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol. 2017; 3(10):1335-1342. PMC: 5824320. DOI: 10.1001/jamaoncol.2017.0589. View

5.

Kim M, Warner R, Ward S, Harpaz N, Roayaie S, Schwartz M . Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors. Neuroendocrinology. 2015; 101(1):58-65. PMC: 4403253. DOI: 10.1159/000371807. View

6.

Norlen O, Montan H, Hellman P, Stalberg P, Sundin A . Preoperative Ga-DOTA-Somatostatin Analog-PET/CT Hybrid Imaging Increases Detection Rate of Intra-abdominal Small Intestinal Neuroendocrine Tumor Lesions. World J Surg. 2017; 42(2):498-505. PMC: 5762814. DOI: 10.1007/s00268-017-4364-1. View

7.

Blazevic A, Hofland J, Hofland L, Feelders R, de Herder W . Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrum. Endocr Relat Cancer. 2017; 25(3):R115-R130. DOI: 10.1530/ERC-17-0380. View

8.

Omori S, Harada N, Toshima T, Takeishi K, Itoh S, Ikegami T . Multiple liver metastases originating from synchronous double cancer of neuroendocrine tumor and rectal cancer: a case report. Surg Case Rep. 2020; 6(1):36. PMC: 7018860. DOI: 10.1186/s40792-020-0800-9. View

9.

Kasai Y, Mahuron K, Hirose K, Corvera C, Kim G, Hope T . Prognostic impact of a large mesenteric mass >2 cm in ileal neuroendocrine tumors. J Surg Oncol. 2019; 120(8):1311-1317. DOI: 10.1002/jso.25727. View

10.

Ito T, Igarashi H, Nakamura K, Sasano H, Okusaka T, Takano K . Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol. 2014; 50(1):58-64. DOI: 10.1007/s00535-014-0934-2. View

Awareness of a Mesenteric Mass As a Common Manifestation of Ileal Neuroendocrine Tumor